Anzeige
Mehr »
Donnerstag, 12.02.2026 - Börsentäglich über 12.000 News
Top-Ergebnisse: 1,75 g/t Gold über 30,4 Meter + massives Tagebau-Potenzial
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
333 Leser
Artikel bewerten:
(2)

Medtech Incubator Announces Launch of New Portfolio Company: Medtech Pitch Partners

SCOTTSDALE, AZ / ACCESS Newswire / June 12, 2025 / MedTech Incubator, a premier accelerator for medical technology companies is proud to announce the launch of its newest portfolio company, Medtech Pitch Partners. This specialized firm is dedicated to empowering early-stage Medtech innovators with strategic pitch development, data room management, and valuation defense, further enhancing the incubator's comprehensive end-to-end solution from startup concept to successful exit. This addition strengthens Medtech Incubator's mission to streamline the growth of companies that are reshaping healthcare through innovative technology.

Medtech Pitch Parnters

Medtech Pitch Parnters
Logo

Medtech Incubator accelerates the development of startups by leveraging its robust team as well as the synergies created by its portfolio, including companies like OrthoEx, Surgio Health, MedTechIntel, and OSP Advisors, in addition to its strategic partnership with BAAT Medical. This ecosystem provides a seamless pathway for portfolio companies, guiding them from ideation through regulatory milestones, market entry, and exit strategies. The launch of Medtech Pitch Partners introduces targeted support for companies seeking responsible amounts of capital to be sure that they are investor-ready from the outset.

Accessible at www.mtpitch.com, Medtech Pitch Partners offers tailored services to help startups articulate their vision and secure funding. The core offerings include crafting compelling, investor-ready pitch decks that transform complex technical innovations into clear, impactful narratives highlighting market potential, patient impact, and financial upside. They also provide expert data room management to ensure all documentation, from regulatory progress to financial projections, is organized and investor-ready. Additionally, Medtech Pitch Partners specializes in valuation defense, utilizing the most commonly regarded valuation methods to be in the appropriate position to have a defensible value proposition not simply a desirable valuation.

"Our mission is to empower Medtech visionaries at their earliest stages, equipping them with the tools to pitch with purpose and build a strong foundation for growth. With the support of Medtech Incubator, we're excited to help drive healthcare innovation forward, one compelling story at a time." said Steven Hall, Principal of MedTech Pitch Partners.

For more information about Medtech Pitch Partners, visit www.mtpitch.com. To learn more about Medtech Incubator and its portfolio of innovative companies, visit www.mtincubator.com.

About Medtech Incubator

MedTech Incubator is a leading accelerator for medical technology startups, dedicated to streamlining the development of innovative devices, diagnostics, and digital health solutions from concept to exit. Based in Scottsdale, Arizona, the incubator leverages its portfolio companies, including OrthoEx, Surgio Health, MedTechIntel, and OSP Advisors, and its partnership with BAAT Medical to provide mentorship, funding opportunities, scalable business operations and a robust network of industry partners to drive transformative healthcare solutions.

About Medtech Pitch Partners

Medtech Pitch Partners is a specialized firm empowering early-stage Medtech innovators to properly position themselves for funding and accelerated growth through strategic pitch development, data room management, and valuation defense. With a focus on integrity, innovation, and impact, the company crafts compelling pitch decks and robust valuation frameworks to transform groundbreaking ideas into transformative healthcare solutions.

Media Contact: Bree Mitchell, VP Marketing at Medtech Incubator

Contact Information

Bree Mitchell
VP Marketing
bree@ospadvisors.com
480-542-5116

.

SOURCE: Medtech Incubator



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/medtech-incubator-announces-launch-of-new-portfolio-company-medtech-p-1038978

© 2025 ACCESS Newswire
Favoritenwechsel - diese 5 Werte sollten Anleger im Depot haben!
Das Börsenjahr 2026 ist für viele Anleger ernüchternd gestartet. Tech-Werte straucheln, der Nasdaq 100 tritt auf der Stelle und ausgerechnet alte Favoriten wie Microsoft und SAP rutschen zweistellig ab. KI ist plötzlich kein Rückenwind mehr, sondern ein Belastungsfaktor, weil Investoren beginnen, die finanzielle Nachhaltigkeit zu hinterfragen.

Gleichzeitig vollzieht sich an der Wall Street ein lautloser Favoritenwechsel. Während viele auf Wachstum setzen, feiern Value-Titel mit verlässlichen Cashflows ihr Comeback: Telekommunikation, Industrie, Energie, Pharma – die „Cashmaschinen“ der Realwirtschaft verdrängen hoch bewertete Hoffnungsträger.

In unserem aktuellen Spezialreport stellen wir fünf Aktien vor, die genau in dieses neue Marktbild passen: solide, günstig bewertet und mit attraktiver Dividende. Werte, die nicht nur laufende Erträge liefern, sondern auch bei Marktkorrekturen Sicherheit bieten.

Jetzt den kostenlosen Report sichern – bevor der Value-Zug 2026 endgültig abfährt!

Dieses exklusive PDF ist nur für kurze Zeit gratis verfügbar.
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.